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Introduction
During the normal wound healing process, three distinct but over-
lapping phases can be distinguished, namely the inflammatory,
proliferation and remodelling phase. During the remodelling
phase, fibroblasts that have migrated into the wound area and
deposited new extracellular matrix molecules (ECM) eventually go
through the process of apoptosis. This results in a relatively acel-
lular scar, which is the end-point of normal wound healing.
Conversely, during abnormal or pathological wound healing,
fibroblasts do not undergo apoptosis, resulting in a hypertrophic
scar [1]. Such a scar contains increased amounts of ECM and
fibroblasts compared to a normal scar. On rare occasions, the scar
may even extend beyond the boundaries of the original wound
(keloid scar). Irrespective of the type of scar that is eventually
formed, significant problems for the patient can arise since 
scars are not only disfiguring but can also cause significant func-
tional impairment.
The polyphenol curcumin has shown to increase wound con-
traction and decrease wound-healing time in full-thickness wound
models in rodents [2]. Following curcumin treatment, the wounds
showed enhanced fibronectin and collagen expression combined
with increased collagen maturation and collagen cross-linking,
which resulted in increased tensile strength. Also in diabetic ani-
mals, curcumin beneficially affected skin wound healing as shown
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by increased formation of granulation tissue that eventually result-
ed in increased neo-vascularization and faster re-epithelization 
[3, 4]. Similarly, curcumin demonstrated to improve wound heal-
ing after gamma-irradiation or to protect against radiation-induced
damage in animal models [5].
It has been described in detail that curcumin induces apopto-
sis in a wide variety of cell lines [6–10]. Although the mechanism
by which curcumin initiates cell death is unclear and strongly
depends on the cell type, reactive oxygen species (ROS) seem to
be a common mediator. Curcumin-induced ROS formation in
human hepatoma cells induced the nuclear factor-erythroid 2-
related factor 2 (Nrf2) transcription factor, which could be blocked
by the antioxidants N-acetyl-L-cysteine (NAC) and vitamin E [11].
Atsumi et al. have also demonstrated that treatment with NAC
blocks curcumin-induced apoptosis in human gingival fibroblasts
and leukemia cells [6, 12].
Panchatcharam et al. observed that curcumin induced the
activity of antioxidant enzymes superoxide dismutase, catalase
and glutathione peroxidase [2] and detoxifying enzymes such as
cytochrome P450 [13] and glutathione s-transferase [14]. For
instance, H2O2-induced damage in keratinocytes and fibroblasts
could be inhibited by curcumin [15]. Furthermore, curcumin can
also induce the cytoprotective enzyme heme oxygenase-1 (HO-1)
in several cell types [16–18]. HO is the enzyme that can break
down heme thereby generating carbon monoxide (CO), free
 ferrous iron and biliverdin. The latter is immediately converted to
bilirubin by biliverdin reductase (BVR). Bilirubin represents one
of the most powerful endogenous antioxidants known so far
[19]. Two isoforms of HO have been characterized, of which HO-2
is considered to be constitutively expressed and responsible for
normal heme capturing and catabolism. On the other hand, HO-1,
which is normally expressed at a low level, is highly inducible by
its substrate heme, various stress-related stimuli and tissue
injury [20].
Here we report that curcumin treatment can induce human der-
mal fibroblast apoptosis and inhibit fibroblast-mediated collagen
gel contraction via a ROS-mediated process, since apoptosis
could be completely blocked by antioxidants such as NAC,
biliverdin and bilirubin. Interestingly, enhanced levels of HO-1 pro-
tect against effects of curcumin and therefore, HO-effector mole-
cules could possibly function as regulators of curcumin-induced
fibroblast apoptosis and contraction, thereby enabling fine-tuning
of the balance between acellular and hypertrophic wound healing.
Materials and methods
Fibroblast culture
Human foreskin-derived fibroblasts were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with high glucose, containing 10% foetal calf
serum (MP Biomedicals, Uden, the Netherlands) and 1% penicillin/
streptomycin/amphotericin B (Invitrogen life sciences, Breda, the
Netherlands) at 37°C in a 5% CO2 atmosphere. Medium was refreshed
every 2–3 days and when the cells reached ~90% confluence they were
subcultured using trypsin-EDTA (Invitrogen) at a 1:3 dilution.
Preparation of porphyrin and biliverdin/bilirubin
solutions
Heme (FePP), cobalt protoporphyrin (CoPP), stannous (tin) mesopor-
phyrin (SnMP), biliverdin and bilirubin were all obtained from Frontier
Scientific, Carnforth, UK. All solutions were freshly prepared as previously
described [21]. In short, the substances were dissolved together with
Trizma base in a 0.1-M NaOH solution and further diluted in H2O. After the
pH was adjusted to pH 8 with HCl, H2O was added to obtain a 2-mM solu-
tion. The solutions were then filter-sterilized, protected from light and
directly used.
Detection of apoptosis induced by 
curcumin using FACS analysis
In this study, FACS analysis was used to differentiate between living, early
apoptotic, late apoptotic/necrotic and necrotic cells by staining with
Annexin V-FITC and propidium iodide (PI). Fibroblasts were plated at 70% 
confluence in 6-well plates and allowed to adhere for at least 6 hrs before
the cells were treated with varying doses of curcumin (2.5–25 M, Sigma-
Aldrich, Zwijndrecht, the Netherlands) for 48 hrs.
To investigate whether the observed curcumin-induced apoptosis was
mediated by reactive oxygen species (ROS) we incubated the cells with the
known antioxidants N-acetyl-L-cysteine (NAC, 6 mM, Sigma-Aldrich), or
with the HO-effector molecules biliverdin or bilirubin (1 M) in the pres-
ence of 25 M curcumin. To block HO-activity during curcumin + NAC
treatment we used the previously described specific non-porphyrin HO-
activity inhibitor QC-15 at a dose of 50 M [22, 23]. Since we observed
that 50-M SnMP in combination with 25-M curcumin affected HO-1
expression and therefore could act as a possible confounder, we opted for
the QC-15 inhibitor to study the effect of HO-activity in all experiments
where 25-M curcumin was used. No effect of QC-15 alone or in combi-
nation with curcumin on the expression of HO-1 was found in this study.
We also studied whether moderately enhanced expression of HO-1 pro-
tects cells against apoptosis. In order to induce HO-1 expression, adherent
fibroblasts were pre-treated for 24 hrs with varying doses (2.5; 5 or 10
M) of curcumin alone or not treated, followed by a 48-hr incubation peri-
od with 25 M curcumin that normally causes apoptosis. In addition, pre-
conditioning using 5 M of curcumin was performed in the absence or
presence of the HO-activity inhibitor SnMP (20 M), followed by exposure
to 25 M curcumin.
Early apoptosis was demonstrated by determining phosphatidyl ser-
ine (PS) exposure on the outside of the cell membrane via Annexin V-
FITC staining. After incubation, all cells were collected and 100,000 cells
were resuspended in 100 l binding buffer containing Annexin V-FITC
and PI according to the manufacturers recommendations (Biovision Inc,
Uithoorn, the Netherlands). Next, samples were incubated for 15 min. at
room temperature (RT) in the dark. As a positive control for the Annexin
V-FITC and PI staining, fibroblasts fixed with 4% paraformaldehyde and
permeabilized by 0.1% saponine were used. Quantification of Annexin V-
FITC and PI binding was performed by a FACScan (BD Biosciences) using
channels FL-1 (Annexin V-FITC) and FL-3 (PI). Cellquest Pro was used to
perform quadrant analysis. All experiments were at least repeated 3 times.
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Measurement of reactive oxygen species (ROS)
To detect ROS formation induced by curcumin, we used the ROS-specific
labelling dye 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein
diacetate, acetyl ester (H2DCFDA, Invitrogen). Fibroblasts were cultured at
80% confluency in DMEM without phenol red and with 10% FCS in a 96-
wells plate suitable for fluorescence measurement (ThermoFischer
Scientific, Vantaa, Finland). Cells were washed once with Hanks’ Balanced
Salt Solution (HBSS, Invitrogen) prior to labelling with 10-M H2DCFDA
in HBSS for 15 min. at 37C. Subsequently, cells were washed once with
HBSS and treated for 90 min. with different concentrations of curcumin
(5, 10 and 25 M) in the presence or absence of 6-mM NAC or 50-M
bilirubin DMEM without phenol red and 1% FCS. As a negative control,
unlabelled cells were used. Afterwards, cells were washed twice with
HBSS and fluorescence was determined using a Fluostar Galaxy fluorom-
eter at excitation 485 nm and emission 520 nm (BMG Lab Technologies,
Offenburg, Germany).
Glutathione assay
Total glutathione (GSH) and oxidized glutathione (GSSG) were determined
according to the method of Tietze and Griffith [24, 25]. In short, adherent
fibroblasts were treated for 24 hrs with 6-mM NAC, 25-M curcumin, the
combination of curcumin and NAC or were not treated. Cells were harvest-
ed by trypsin/EDTA and 25,000 cells were resuspended in 200 l 10 mM
HCl, lysed by 3 freeze-thaw cycles and cell debris was pelleted by centrifu-
gation. Proteins were precipitated using 5-sulfosalicylic acid (1% final con-
centration, Sigma-Aldrich) for 5 min. on ice, after which samples were cen-
trifuged at 4C for 5 min. The supernatant was neutralized with NaOH and
divided over 2 eppendorf cups. To determine the level of oxidized GSH, 
2-vinylpyridine (end concentration 2%, Sigma-Aldrich) was added to one
of the two cups, mixed and incubated for 1 hr at RT. Total GSH and oxidized
GSH was determined in 10 l samples to which NADPH (final concentration
0.42 mM, Roche Applied Science), 5,5-dithiobis-(2-nitrobenzoic acid)
(DTNB, final concentration 1.2 mM, Sigma-Aldrich) and 0.5 U glutathione
reductase (Sigma-Aldrich) were added in such a way that the total volume
was 100 l. Immediately after addition of glutathione reductase, the extinc-
tion was measured every 10 sec. at 412 nm for 4 min. using the BioRad
Benchmark Plus microplate spectrophotometer. Concentration of GSH was
calculated from the slope of the GSH standards.
HO-1 Western procedure
The effect of exposure of fibroblasts to increasing doses of curcumin on the
HO-1 protein expression was studied. Therefore, fibroblasts were seeded in 6-
well plates at 70% confluence, allowed to adhere and subsequently treated for
24 hrs with curcumin (2.5–27.5 M) or 10 M of the known HO-1 inducers
heme and CoPP. Furthermore, the effect of 6-mM NAC and the combination
of 25-M curcumin with 6-mM NAC on HO-1 expression was investigated.
After treatment, cells were harvested using trypsin-EDTA, pelleted by centrifu-
gation and lysed for 30 min. on ice using lysis buffer (1 mM EDTA, 0.5%
Triton-X-100, 25 g/ml leupeptin, 25 g/ml pepstatin, 100 M phenyl-
methanesulphonylfluoride, 3 g/ml aprotinin in PBS, pH 7.2, all Sigma-
Aldrich). Cell lysates were centrifuged for 10 min. at 20,000  g at 4C and
20-g total protein was separated by SDS/PAGE using a 12.5% gel.
Subsequently, proteins were blotted onto a nitrocellulose membrane using a
BioRad wet blotting system. Afterwards, the membrane was blocked
overnight at 4C using Odyssey Blocking Buffer (Westburg BV, Leusden, the
Netherlands). The blot was then incubated for 1 hr at RT with rabbit-anti-HO-
1 Ab (1:5000; Stressgen/ITK, Uithoorn, the Netherlands). Mouse-anti--actin
Ab was simultaneously incubated to serve as a protein loading control
(1:100,000, Sigma-Aldrich). Antibodies were diluted in Odyssey Blocking
Buffer containing 0.1% Tween-20. Afterwards, the membrane was washed
three times for 10 min. with PBS containing 0.1% Tween-20. The secondary
antibodies, goat-anti-mouse Alexa Fluor 680 (1:20,000, Rockland,
Heerhugowaard, the Netherlands) and goat-anti-rabbit IRDye 800 (1:20,000
Sigma-Aldrich) were incubated for 45 min. at RT in Odyssey Blocking Buffer
containing 0.1% Tween-20 and 0.01% SDS. After thorough washing, the
membrane was scanned using the Odyssey Infrared Imaging System (LI-COR
Biosciences). Expression of HO-1 was assessed using channel 800 and -
actin expression was determined using channel 700. Intensity of the bands
was determined using the Odyssey application software.
HO-activity assay
To determine whether the curcumin-induced HO-1 proteins were active, we
performed an HO-activity assay. Therefore, the cells were treated as
described in the previous section and 100,000 cells were resuspended in
89.9 l 0.1 M phosphate buffer, 2 mM MgCl2 (pH 7.4) and subsequently
lysed by 3 freeze-thaw cycles. To the cell lysate, 10.1-l master mix was
added that consisted of 2.5 l 80 mM glucose-6-phosphate, 0.1 l 0.5 U/l
glucose 6-phospate dehydrogenase in 5 mM glycine (both Sigma-Aldrich), 5
l 32 mM NADPH tetrasodium salt (Roche Applied Science, Almere, the
Netherlands) and 2.5 l 2 mM heme. The samples were incubated for 45–60
min. at 37C in the dark. Next, 100 l methanol was added and the samples
were centrifuged at 13,000  g. A 50-l aliquot of this sample was run on
an HPLC (Spectra-Physics Analytical, Spectrasystem SCM400) equipped
with a 5-m Discovery C18 column and a Discovery C18 Supelguard
Cartridge 5 m particle size precolumn (both Sigma-Aldrich). Separation
was done by a mixture of 80% solvent A (40% 100 mM NH4Ac, pH 5.5, 5%
methoxy ethanol and 50% methanol [all Sigma-Aldrich]) and 20% solvent B
(5% methoxy ethanol and 95% methanol) over a 20-min. time interval at a
flow rate of 1 ml/min. Biliverdin and bilirubin were detected at a wavelength
of 377 and 450 nm, respectively. Standards of biliverdin and bilirubin (both
Frontier Scientific) were also run in order to quantify the amount of
biliverdin/bilirubin found in the samples.
Collagen gel contraction assay
We tested if curcumin affected fibroblast-mediated gel contraction.
Collagen gels consisted of 0.14% rat-tail collagen type I (Serva
Electrophoresis, Brunschwig chemie, Amsterdam, the Netherlands), 1x
MEM, 0.1 M HEPES and 30 mM sodium bicarbonate and the pH was neu-
tralized with NaOH. Per ml collagen gel 50,000 cells were incorporated.
One ml of the collagen-cell mix was pipetted carefully in a well of a 24-wells
plate, which was previously blocked with 1% BSA, and the gel was allowed
to gelate at 37C and 5% CO2. After 45 min., DMEM + 10% FCS was added
containing the tested substances. Gel contraction was determined after 24
hrs by scanning the 24 wells plate using a flat bed scanner and a comput-
er. The surface area was determined using image analysis software
(ImageJ, U.S. National Institutes of Health, Bethesda, MD, USA,
J. Cell. Mol. Med. Vol 13, No 4, 2009
715© 2009 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 1 Curcumin induces fibroblast apoptosis. Fibroblast morphology (A–D). Adherent fibroblasts were not treated (A) or treated with 5 m (B), 10 M
(C) or 25 M (D) curcumin for 48 hrs. Images were taken using a light microscope and a digital camera. Original magnification 40. Note rounding of
fibroblasts and dead cells in the 25 M group. FACS analysis of fibroblasts after curcumin treatment (E–F). Adherent fibroblasts were treated for 48 hrs
with the indicated doses of curcumin. Afterwards, all cells were collected and stained with Annexin V-FITC and PI. Staining intensity was determined for
10,000 cells using flow cytometry and subsequent quadrant analysis. The mean  S.D. are shown from the living (E) and early apoptotic (F) cell frac-
tions from 5 independent experiments. ***P < 0.001 compared to untreated.
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http://rsb.info.nih.gov/ij/, 1997–2007). At the end of the experiment, the
wet weight of the gels was determined.
Statistics
Statistics were performed using GraphPad Prism 4.03 software via a one-
way ANOVA followed by the Newman-Keuls multiple comparison test.
Differences between groups were stated to be statistically significant 
when P < 0.05.
Results
High doses of curcumin induce dermal fibroblast
apoptosis
Curcumin has shown to influence the wound healing process in
vivo. We investigated the effect of different doses of curcumin on
dermal fibroblast morphology and cell death by microscopy.
Treatment with 5- and 10-M curcumin for 48 hrs did not affect
fibroblast morphology, whereas treatment with 25-M curcumin
caused rounding of the cells and cell death (Fig. 1A–D).
Treatment of fibroblasts with 25-M curcumin for 24 hrs induced
a too mild apoptosis-inducing effect (<15% of the cells positive
for Annexin V-FITC) to be reproducible. After 48 hrs of treatment
with 25-M curcumin, a far more reproducible level of apoptosis
of ~60% could be measured and therefore this time point 
was taken to further study the effect of curcumin on fibroblast
apoptosis.
We next investigated whether this curcumin-induced cell death
was a result of fibroblast necrosis or apoptosis. Using annexin-V-
FITC/propidium iodide (PI) stainings and flow cytometry, we show
that treatment with 25 M curcumin for 48 hrs resulted in
increased annexin-V-FITC staining (Fig. 1E). The percentage of liv-
ing cells was significantly decreased from 90% in the untreated
group to 54% after curcumin treatment (P < 0.001). Moreover, 25-
M curcumin caused a significant increase in the percentage of
early apoptotic cells (Fig. 1F). In contrast, treatment with 5-M
curcumin for 48 hrs did not significantly change the percentage of
living or early apoptotic cells compared to untreated cells.
Treatment with 10-M curcumin for 48 hrs causes a very mild
increase in annexin V-FITC positive cells, although this effect was
not statistically significant (Fig. 1E). Only a very small percentage
stained positive for PI, indicating that the cells were not necrotic
(data not shown).
Thus, high doses of curcumin induced dermal fibroblast apop-
tosis as indicated by annexin V-FITC staining.
Curcumin directly induces ROS formation
It has been suggested that curcumin-induced apoptosis in dermal
fibroblasts was mediated by ROS. To investigate whether curcum-
in causes ROS formation, we used the ROS-specific labelling dye
H2DCFDA. Table 1 shows that treatment with 25-M curcumin
causes significantly more ROS formation than untreated cells or
cells treated with lower doses of curcumin (P < 0.001). In unla-
belled cells treated with the different doses of curcumin or NAC or
bilirubin no fluorescent signal could be detected (data not shown).
Importantly, co-exposure of curcumin with NAC or bilirubin did
not result in a significant enhanced fluorescent signal at 520 nm
by 25 M curcumin. The effect of the antioxidants was not tested
on lower doses of curcumin since no significant ROS production
was found using these doses. This experiment demonstrates that
25 M of curcumin is able to directly cause ROS formation and
that this can be blocked by the presence of the antioxidant NAC 
or bilirubin.
Table 1 Twenty-five M Curcumin induces reactive oxygen species (ROS) formation which can be blocked by NAC and bilirubin
Adherent cells were first labelled with the ROS-specific probe H2-DCFDA and then treated with different doses of curcumin for 90 min. in the absence
or presence of 6-mM NAC or 50-M bilirubin. Subsequently, fluorescence was determined at excitation 485 nm and emission 520 nm. The ROS level
of untreated cells was stated as 1 and the other values were normalized accordingly. Shown are the mean ± S.E.M. of 3 independent experiments.
*Significantly different from other treatments (P < 0.001). n.d = not determined.
Treatment
Curcumin + NAC + Bilirubin
Mean S.E.M. Mean S.E.M. Mean S.E.M.
Untreated 1.00 0.294 0.99 0.016 0.95 0.017
5 M curcumin 1.17 0.113 n.d. n.d.
10 M curcumin 2.23 0.409 n.d. n.d.
25 M curcumin 7.62* 1.509 1.16 0.164 1.27 0.081
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Curcumin-induced ROS formation causes apoptosis
To prove that curcumin-induced ROS formation caused fibroblast
apoptosis, we incubated fibroblasts with curcumin in the presence
or absence of the known antioxidants NAC, biliverdin or bilirubin.
Figure 2 clearly shows that 6-mM NAC completely prevented cur-
cumin-induced apoptosis and that the percentage of living and
early apoptotic cells returned to normal values. The antioxidants
biliverdin and bilirubin also significantly inhibited curcumin-
induced apoptosis when administered in a concentration of 1 M
(P < 0.001). These results strongly suggest that ROS are involved
in curcumin-induced apoptosis in fibroblasts.
Glutathione and curcumin
Besides having antioxidant properties, NAC can serve as a cys-
teine donor, causing increased levels of the cytoprotective agent
glutathione (GSH) and thus protect cells from cellular stress
such as ROS. In order to analyse possible effects of GSH on cur-
cumin-induced apoptosis, we determined total GSH and oxidized
GSH content after curcumin or curcumin + NAC treatment. Our
results indicate that treatment with 25-M curcumin for 24 hrs
does not alter total GSH content or the GSH/GSSG balance, com-
pared to untreated cells (Table 2). Also at other time points (6 or
48 hrs), no effect of 25-M curcumin on the GSH content was
observed (data not shown). Unexpectedly, we did not observe an
increase in GSH content after treatment with the GSH precursor
NAC (6–48 hrs treatment, Table 2 and data not shown). However,
the combination of NAC and curcumin resulted in a significant 
2-fold increase in total GSH content but this effect was accom-
panied by a 3-fold increase in GSSG level, compared to untreat-
ed cells. As a result, the net balance of GSH/GSSG, a measure for
cellular stress, was worse after curcumin-NAC treatment than in
the untreated situation or after treatment with curcumin. Taken
together, curcumin does not seem to have a direct effect on the
GSH/GSSG content but it induces cellular stress that will lead to
increased GSH synthesis in the presence of a cysteine donor
such as NAC.
Curcumin dose-dependently induces HO-1 protein
expression and activity
Since biliverdin and bilirubin are down-stream products of heme
degradation by the rate-limiting enzyme HO, we investigated
whether pre-induction of HO-1 could protect against curcumin-
induced apoptosis in fibroblasts. Therefore, we first examined
whether doses of curcumin, not affecting fibroblast viability,
could induce HO-1 expression in fibroblasts. Figure 3 demon-
strates that, as expected, both 10-M heme and 10-M CoPP
cause a clear induction in the expression of HO-1. Differential
effects of curcumin (0–27.5 M) on HO-1 expression are clear-
ly visible; from 5 M up to a dose of 17.5 M, a significant
induction of HO-1 protein can be observed, whereas from 20 to
27.5 M no significant difference from basal levels could be
detected. The maximal induction of ~50-fold compared to
untreated cells was observed between 10 and 15 M curcumin
(P < 0.001). HO-1 expression was at basal levels after treatment
with 25-M curcumin.
To determine if curcumin-induced HO is enzymatically active,
we performed an HO-activity assay based on the detection of
bilirubin using HPLC. In Figure 3C, a clear dose response of cur-
cumin on HO-activity is seen with a maximal induction of ~6-fold
at a dose of 10–15 M curcumin, compared to untreated cells 
(P < 0.001). However, already with a low dose of 5-M curcumin
Fig. 2 Curcumin-induced ROS formation causes apoptosis. Adherent
fibroblasts were treated for 48 hrs with 6 mM NAC, 1 M biliverdin or 1
M bilirubin in the presence or absence of 25 M curcumin. As a nega-
tive control, cells were not treated. Afterwards, all cells were collected and
stained with Annexin V-FITC and PI and quadrant analysis after flow
cytometry was performed. The mean  S.D. are shown from the living
(A) and early apoptotic (B) cell fractions from 5 independent experiments.
**P < 0.01 and ***P < 0.001 compared to 25-M curcumin.
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a significant increase of 2.5-fold in HO-activity was observed 
(P < 0.001). FePP and CoPP (10 M) induced HO-activity similar
to 5-M curcumin. Treatment with 25-M curcumin did not lead
to HO-activity, which is in line with the HO-1 protein expression
patterns as observed by Western blotting.
NAC-mediated protection against 
curcumin-induced apoptosis involves HO-1
We further investigated how NAC prevented curcumin-induced
fibroblast apoptosis and studied HO-1 expression and HO-activ-
ity. Figure 4A and B shows that either 25-M curcumin or 6-mM
NAC did not induce HO-1 protein expression or activity.
Interestingly, the combination of curcumin with NAC strongly
induced HO-1 expression, and, furthermore, the induced HO-1
was shown to be active. These results suggest a role for HO-1 in
the protection against curcumin-induced apoptosis by NAC.
Indeed when we blocked HO-activity using the specific HO-activ-
ity inhibitor QC-15 in the presence of the curcumin-NAC combi-
nation, we observed a significant inhibition of the rescuing
effects of NAC on curcumin-induced apoptosis (Fig. 5A–C).
Combined treatment of curcumin and NAC increased the fraction
of living cells by 35% compared to curcumin alone (P < 0.001).
When we inhibited HO-1-activity in the curcumin-NAC group by
QC-15, the fraction of living cells was significantly decreased 
by 17% (P < 0.01). Moreover, application of the HO-activity
inhibitor together with curcumin and NAC significantly increased
the fraction of early apoptotic cells by 59%, compared to treat-
ment with the curcumin-NAC combination (P < 0.05). Similarly,
also the fraction of late apoptotic cells is significantly increased
in the curcumin-NAC-QC group, 229  1.3% compared to a nor-
malized fraction of 100  10.4% in the curcumin-NAC treated
group (P < 0.001). These results show that HO-activity, at least
partially, mediates the rescuing effects of NAC on curcumin-
induced apoptosis.
Pre-treatment with low doses curcumin protects
against 25 mM curcumin-induced apoptosis
HO has been described as an enzyme with cytoprotective func-
tions. Therefore, we studied whether pre-induction of HO-1 would
protect against apoptosis induced by 25-M curcumin. In Figure 6,
Table 2 Determination of total glutathione (GSH) and oxidized glutathione (GSSG)
GSH levels were determined in cell lysates of treated cells using the reaction of GSH with DTNB, which results in a yellow product. To determine GSSG
levels only, 2-vinylpyridine was added to the cell lysate, which prevents reduction of GSSG to GSH by GSH-reductase. Concentrations were determined
from GSH standards. Shown are mean ± S.E.M. of GSH and GSSG concentrations of 3 independent experiments. * and *** = significantly different from
other treatments (P < 0.05 and P < 0.001, respectively).
Treatment
Total GSH (M) GSSG (M)
Mean S.E.M. Mean S.E.M.
Untreated 18.6 1.9 2.6 1.7
6 M NAC 18.9 1.3 3.5 1.4
25 M curcumin 18.9 5.0 2.9 1.9
25 M curcumin + 6 mM NAC 36.5** 3.1 7.9* 1.8
Fig. 3 Dose-dependent induction of HO-1 protein expression and HO-activity by curcumin. HO-1 protein expression was studied in fibroblasts treat-
ed for 24 hrs with different doses of curcumin. As a positive control, cells were treated with 10-M FePP or CoPP. Cell lysates were prepared and
proteins were separated by SDS-PAGE and subsequently blotted onto a nitrocellulose membrane. HO-1 protein and beta-actin (as a loading control)
were stained with specific antibodies. Detection was done with the appropriate fluorescently labelled secondary antibodies and the Odyssey Infrared
Imaging System. (A) Results of the Western blot showing bands corresponding to HO-1 and beta-actin protein. (B) Relative quantification of HO-1
proteins bands corrected for beta-actin from 5 independent experiments (mean  S.D.) (C) Determination of HO-activity by quantifying bilirubin lev-
els via HPLC. For details on the HO-activity assay, see ‘materials and methods’ section. The mean  S.D. of the area under the curve of the peak are
shown corresponding to bilirubin of 5 independent experiments. The bilirubin peak in the untreated group was set at 1 and the bilirubin peaks in the
other groups were normalized accordingly. *P < 0.05, **P < 0.01 and **P < 0.001 compared to the untreated group.
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it is shown that 5-M curcumin pre-treatment followed by 25-M
curcumin treatment indeed causes a significant increase in the
percentage of living fibroblasts, compared to cells that received no
pre-treatment (P < 0.001). This observation was accompanied by
a significant decrease in the percentage dead cells after pre-treat-
ment with 5-M curcumin (P < 0.01). Pre-treatment with 2.5-M
curcumin had similar but milder effects (data not shown).
Importantly, the protective effect of preconditioning was blocked
significantly when co-treated with the HO-activity inhibitor SnMP
(P < 0.05). Taken together, these data indicate that a modest up-
regulation of HO-1 protein expression and HO-activity by precon-
ditioning with curcumin, subsequently, had significant cytoprotec-
tive effects in fibroblasts.
Fig. 4 HO-1 protein expression and HO-activity in fibroblasts treated with
curcumin, NAC or the combination. Adherent cells were treated with 25-
M curcumin, 6-mM NAC or the combination for 24 hrs. The HO-1 level or
activity in the untreated group was set at 1. (A) Quantification of Western
blot analysis for HO-1, and (B) HO-activity assay. For details on the proce-
dures, see ‘materials and methods’ section. Shown are the mean  S.D.
from 5 independent experiments. ***P < 0.001 compared to untreated.
Fig. 5 HO-activity mediates rescue of curcumin-induced apoptosis by
NAC. Adherent fibroblasts were treated for 48 hrs with the combination 25
M curcumin + 6 mM NAC, in the presence or absence of the HO- activ-
ity inhibitor QC-15 (50 M). Negative controls included all single treat-
ments and non-treated cells. Afterwards, all cells were collected and
stained with Annexin V-FITC and PI. Subsequently, flow cytometry and
quadrant analysis was performed. To compare different experiments, the
percentage of cells per quadrant in the curcumin-NAC group was set at
100% and the other values were normalized accordingly. Shown are the
mean  S.D. of the living (A), early apoptotic (B) and (C) late apoptotic
cell fractions of 6 independent experiments. ***P < 0.001 compared to
all other treatment. Statistical significance between curcumin-NAC and
curcumin-NAC-QC-15 treatments is indicated, where *P < 0.05, **P <
0.01 and ***P < 0.001.
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Curcumin inhibits fibroblast-mediated 
collagen gel contraction
Next, we investigated if curcumin influenced fibroblast-mediated
collagen gel contraction and whether this effect of curcumin could
be inhibited by antioxidant treatment. As Figure 7A shows, 25-M
curcumin prevented fibroblast-mediated collagen gel contraction,
whereas lower doses of curcumin or 6-mM NAC had no effect.
When curcumin was removed by replacement of the medium, gel
contraction resumed normally (data not shown). Interestingly, gel
contraction after treatment with 25-M curcumin in combination
with 6-mM NAC returned to normal untreated levels. This rescuing
effect of NAC is at least partially mediated by HO-activity since co-
exposure of fibroblast-populated gels to the combination curcumin-
NAC in the presence of the specific HO-inhibitor QC-15 resulted 
in a significantly decreased contraction, compared to treatment
with curcumin-NAC alone (P < 0.01) (Fig. 7B). High curcumin 
(>25 M) can inhibit in vitro wound contraction, which can be
counteracted by antioxidant treatment and this is at least partially
mediated by HO-activity.
Discussion
Fast wound closure and a short wound healing time have always
been thought of as beneficial because of the reduced risk of infec-
tion. However, accelerated wound contraction can exacerbate scar
formation [1]. Nowadays, antibiotics/antimycotics are very effi-
cient in combating infections and consequently allow for slower
wound closure. Therefore, we set out to identify possible path-
ways to slow down wound contraction and thereby reduce scar
formation. Since regulation of fibroblast apoptosis is of great
importance for controlling scar formation and because the spice
curcumin has shown to induce apoptosis in a variety of cell types
[6–10], we investigated the effects of curcumin on human dermal
fibroblasts in detail. We show here that a high concentration of
curcumin (>25 M) can induce fibroblast apoptosis in vitro 
and consequently inhibit fibroblast-mediated collagen gel contrac-
tion. We show that these processes are mediated by ROS, since
curcumin directly induced ROS formation and the effects of cur-
cumin could be completely blocked by treatment with 
various antioxidants.
It has been demonstrated that GSH and curcumin can interact,
thereby blocking the effect of curcumin [26, 27]. The inhibiting
effect of the GSH-precursor NAC on curcumin-induced apoptosis
could be based on a similar quenching of curcumin. However, the
stability of curcumin and its subsequent activity can be strongly
improved by the addition of GSH or NAC, suggesting that GSH
does not interfere with curcumin activity [28]. Additionally, sever-
al studies show that curcumin treatment results in an increased
GSH content [29–31]. Since we found no evidence for an interac-
tion of curcumin with GSH or NAC, we believe that our findings
concerning the effect of NAC on curcumin-induced apoptosis and
inhibition of gel contraction are the result of the antioxidant prop-
erties of NAC. This is further supported by our observation that
also the HO-derived antioxidants biliverdin and bilirubin very
potently inhibited apoptosis caused by curcumin in a dose 6000-
fold lower than NAC. This observation underscores the powerful
potency of bilirubin and biliverdin as antioxidants. Moreover, this
strongly suggests a role for HO-activity in the inhibition of cur-
cumin-induced apoptosis since biliverdin and bilirubin are both
downstream signalling products of heme metabolism.
There exists a clear relationship between the heme–heme oxy-
genase (HO) system and the early phases of wound healing. Free
Fig. 6 Pre-treatment with low doses of cur-
cumin protects against apoptosis induced by
25 M curcumin. Adherent fibroblasts were
treated for 24 hrs with 5 M curcumin alone
or in combination with 20 M SnMP. Control
cells were not pre-treated. Subsequently,
medium was changed and the cells were
incubated with 25 M curcumin for 48 hrs.
All cells were collected and stained with
Annexin V-FITC and PI. Using flow cytome-
try, the staining intensity of the cells for
Annexin V-FITC and PI was determined. The
effect of 25 M curcumin without pre-treat-
ment was stated as 100%. Shown is the
quantification of quadrant analysis of 5 inde-
pendent experiments (mean  S.D.).
Asterisks indicate statistically significant dif-
ferent from control cells, *P < 0.05, **P <
0.01, ***P < 0.001 and #P < 0.05 compared
to 5 M curcumin as pre-treatment.
Fig. 7 Antioxidant treatment
rescues curcumin-induced
inhibition of fibroblast-medi-
ated collagen gel contraction.
(A) Fibroblasts were incorpo-
rated in collagen gels and gels
were treated with curcumin (5,
10 or 25 M) in the presence
or absence of 6 mM NAC. Gels
were allowed to contract for
24 hrs after which the surface
area (left axis) and wet weight
(right axis) of the gels was
determined. (B) HO-activity
induced by 25-M curcumin +
NAC was blocked by QC-15
(50 M). Shown are the mean
 S.E.M. of 3 independent
experiments. ***P < 0.001
compared to all treatments
and #P < 0.05 compared to
the untreated group.Statistical
significance between curcum-
in-NAC and curcumin-NAC-
QC-15 treatments is also indi-
cated (**P < 0.01).
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heme is released in large quantities following tissue damage and 
free heme contributes to the inflammatory reaction. In the latter
stages of the inflammatory response macrophages expressing
high levels of HO-1 protein, infiltrate the wound bed [32, 33].
Moreover, also infiltrating fibroblasts show elevated levels of the
HO-1 protein [33]. This increase in HO-1 expression and activity
has shown to be involved in the resolution of inflammation [21,
34]. However, the role of the HO system during the later stages of
wound healing and scar formation is poorly understood and war-
rants further investigation.
Interestingly, low concentrations of curcumin (10–15 M)
strongly induced HO-1 protein expression in dermal fibroblasts
in a dose-dependent fashion. Curcumin was much more potent
than the known HO-inducers heme and CoPP. The mechanism
by which curcumin induces HO-1 expression is complex but is
most likely redox status-dependent, since NAC could almost
completely attenuate HO-1 expression induced by 10 M cur-
cumin (data not shown). Cells can respond to curcumin-
induced ROS by inducing cytoprotective genes such as HO-1
through the transcription factors AP-1, NF-B and Nrf2 [35].
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Although, a reduction of ROS causes a block in the transcription
of HO-1 in several cell systems [36–38], Scapagnini et al.
showed that 1-mM NAC failed to prevent HO-1 induction in
astrocytes following curcumin administration, implying that
ROS where not involved in HO-1 induction in this model [17].
Interestingly, although both 25-M curcumin and 6-mM NAC
alone did not induce HO-1 expression in fibroblasts, the combi-
nation resulted in a strong induction of HO-1 expression and
activity, in a fashion that likely does not involve ROS. This
strongly suggests that HO-induction is involved in NAC-mediated
protection against apoptosis and contraction, which is support-
ed by our finding that addition of HO-activity inhibitors partly
blocks the effects of NAC.
The protective actions of HO-activity are further supported
by our findings that also preconditioning of fibroblasts with low
doses curcumin protected them against apoptosis induced by a
high dose of curcumin. This protective preconditioning effect
was likely mediated by HO-1 induction since the protective
effect was attenuated in the presence of a HO-activity inhibitor.
We have shown that this preconditioning increased both the
expression and activity of HO, resulting in increased bilirubin
production in the cell. However, we cannot rule out that also CO
or ferritin up-regulation are involved in HO-mediated protection
against curcumin-induced apoptosis. Ferritin is rapidly induced
by free ferrous iron (as is generated by heme degradation by
HO) and its anti-apoptotic function most likely depends on the
prevention of ROS formation by rendering the pro-oxidative iron
inactive [39, 40] CO can protect against apoptosis by the acti-
vation of the cGMP pathway by increasing sGC activity [41].
Furthermore, CO can increase anti-apoptotic pathways by mod-
ulating p38 MAPK signalling [42] and CO can induce NF-kB-
dependent anti-apoptotic (cIAP2 and A1) genes that protect
against TNF-	-mediated apoptosis [43]. Further research is
warranted to clarify whether CO or ferritin are indeed involved in
the rescue of curcumin-induced apoptosis.
The cytoprotective properties of HO-preconditioning are in line
with earlier observations in different cell systems. Soares et al.
showed that preinduction of HO-1 gene expression was associated
with cardiac xenograft survival [44]. Furthermore, in murine
fibroblasts the overexpression of HO-1 inhibited TNF-	-induced
apoptosis, which was not observed in the presence of the HO-
activity blocker tin protoporphyrin [45].
Curcumin has been shown to decrease wound-healing time
and increase contraction in wound-healing studies in rodents [2,
5]. Here, we show in an in vitro model that high concentrations
(>25 M) of curcumin inhibit contraction. This discrepancy
between in vivo and in vitro could be the result of the curcumin
dose used or the antioxidant status during in vivo wound healing.
Indeed, it has been demonstrated that curcumin can increase
superoxide dismutase, catalase and GSH levels in vivo [2, 4].
In summary, we have demonstrated that a concentration of
25-M curcumin induced dermal fibroblast apoptosis and inhib-
it collagen gel contraction via a ROS-mediated mechanism. In
addition, we showed that pre-conditioning of fibroblasts, resulting
in enhanced HO-1 expression and HO-activity, protects against
curcumin-induced apoptosis. Our results indicate that curcumin
in high concentrations may be a therapeutic strategy to aid in the
prevention or reduction of hypertrophic scar formation and that
via antioxidants or through modulation of HO-activity or admin-
istration of HO-effector molecules curcumin-induced fibroblast
apoptosis can be regulated.
Acknowledgements
We thank P.H.H. van den Broek for excellent technical assistance regarding
the heme oxygenase activity assay. A. Scharstuhl and S.W.C Pennings are
funded by a grant from the Dutch Burns Foundation (# 05.104). F.A.D.T.G.
Wagener is supported by a VENI grant from the Netherlands Organization
for Scientific Research and the Van Leersum Foundation.
References
1. Nedelec B, Shankowsky H, Scott PG,
Ghahary A, Tredget EE. Myofibroblasts
and apoptosis in human hypertrophic
scars: the effect of interferon-alpha2b.
Surgery. 2001; 130: 798–808.
2. Panchatcharam M, Miriyala S, Gayathri
VS, Suguna L. Curcumin improves wound
healing by modulating collagen and
decreasing reactive oxygen species. Mol
Cell Biochem. 2006; 290: 87–96.
3. Sidhu GS, Mani H, Gaddipati JP, Singh
AK, Seth P, Banaudha KK, Patnaik GK,
Maheshwari RK. Curcumin enhances
wound healing in streptozotocin induced
diabetic rats and genetically diabetic
mice. Wound Repair Regen. 1999; 7:
362–74.
4. Sidhu GS, Singh AK, Thaloor D,
Banaudha KK, Patnaik GK, Srimal RC,
Maheshwari RK. Enhancement of wound
healing by curcumin in animals. Wound
Repair Regen. 1998; 6: 167–77.
5. Jagetia GC, Rajanikant GK. Role of cur-
cumin, a naturally occurring phenolic
compound of turmeric in accelerating the
repair of excision wound, in mice whole-
body exposed to various doses of
gamma-radiation. J Surg Res. 2004; 120:
127–38.
6. Atsumi T, Murakami Y, Shibuya K,
Tonosaki K, Fujisawa S. Induction of
cytotoxicity and apoptosis and inhibition of
cyclooxygenase-2 gene expression, by
curcumin and its analog, alpha-
diisoeugenol. Anticancer Res. 2005; 25:
4029–36.
7. Chan WH, Wu HY, Chang WH. Dosage
effects of curcumin on cell death types in a
human osteoblast cell line. Food Chem
Toxicol. 2006; 44: 1362–71.
8. Chen HW, Huang HC. Effect of curcumin
on cell cycle progression and apoptosis in
vascular smooth muscle cells. Br J
Pharmacol. 1998; 124: 1029–40.
9. Dujic J, Kippenberger S, Hoffmann S,
Ramirez-Bosca A, Miquel J, az-Alperi J,
Bereiter-Hahn J, Kaufmann R, Bernd A. Low
concentrations of curcumin induce growth
arrest and apoptosis in skin keratinocytes
only in combination with UVA or visible light.
J Invest Dermatol. 2007; 127: 1992–2000.
724 © 2009 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
10. Kuo ML, Huang TS, Lin JK. Curcumin, an
antioxidant and anti-tumor promoter,
induces apoptosis in human leukemia
cells. Biochim Biophys Acta. 1996; 1317:
95–100.
11. McNally SJ, Harrison EM, Ross JA,
Garden OJ, Wigmore SJ. Curcumin
induces heme oxygenase 1 through gener-
ation of reactive oxygen species, p38 acti-
vation and phosphatase inhibition. Int J
Mol Med. 2007; 19: 165–72.
12. Atsumi T, Tonosaki K, Fujisawa S.
Induction of early apoptosis and ROS-gen-
eration activity in human gingival fibrob-
lasts (HGF) and human submandibular
gland carcinoma (HSG) cells treated with
curcumin. Arch Oral Biol. 2006; 51:
913–21.
13. Ciolino HP, Daschner PJ, Wang TT, Yeh
GC. Effect of curcumin on the aryl hydro-
carbon receptor and cytochrome P450 1A1
in MCF-7 human breast 
carcinoma cells. Biochem Pharmacol.
1998; 56: 197–206.
14. Piper JT, Singhal SS, Salameh MS,
Torman RT, Awasthi YC, Awasthi S.
Mechanisms of anticarcinogenic proper-
ties of curcumin: the effect of curcumin on
glutathione linked detoxification enzymes
in rat liver. Int J Biochem Cell Biol. 1998;
30: 445–56.
15. Phan TT, See P, Lee ST, Chan SY.
Protective effects of curcumin against
oxidative damage on skin cells in vitro: its
implication for wound healing. J Trauma.
2001; 51: 927–31.
16. Motterlini R, Foresti R, Bassi R, Green
CJ. Curcumin, an antioxidant and anti-
inflammatory agent, induces heme oxyge-
nase-1 and protects endothelial cells
against oxidative stress. Free Radic Biol
Med. 2000; 28: 1303–12.
17. Scapagnini G, Foresti R, Calabrese V,
Giuffrida Stella AM, Green CJ, Motterlini
R. Caffeic acid phenethyl ester and cur-
cumin: a novel class of heme oxygenase-1
inducers. Mol Pharmacol. 2002; 61:
554–61.
18. Tourkina E, Gooz P, Oates JC, Ludwicka-
Bradley A, Silver RM, Hoffman S.
Curcumin-induced apoptosis in scleroder-
ma lung fibroblasts: role of protein kinase
cepsilon. Am J Respir Cell Mol Biol. 2004;
31: 28–35.
19. Baranano DE, Rao M, Ferris CD, Snyder
SH. Biliverdin reductase: a major physio-
logic cytoprotectant. Proc Natl Acad Sci
USA. 2002; 99: 16093–8.
20. Maines MD. The heme oxygenase system:
a regulator of second messenger gases.
Annu Rev Pharmacol Toxicol. 1997; 37:
517–54.
21. Wagener FA, Eggert A, Boerman OC,
Oyen WJ, Verhofstad A, Abraham NG,
Adema G, van Kooyk Y, de Witte T, Figdor
CG. Heme is a potent inducer of inflamma-
tion in mice and is counteracted by heme
oxygenase. Blood. 2001; 98: 1802–11.
22. Kinobe RT, Dercho RA, Vlahakis JZ, Brien
JF, Szarek WA, Nakatsu K. Inhibition of
the enzymatic activity of heme oxygenases
by azole-based antifungal drugs. J
Pharmacol Exp Ther. 2006; 319: 277–84.
23. Vlahakis JZ, Kinobe RT, Bowers RJ, Brien
JF, Nakatsu K, Szarek WA. Synthesis and
evaluation of azalanstat analogues as heme
oxygenase inhibitors. Bioorg Med Chem
Lett. 2005; 15: 1457–61.
24. Griffith OW. Determination of glutathione
and glutathione disulfide using glutathione
reductase and 2-vinylpyridine. Anal
Biochem. 1980; 106: 207–12.
25. Tietze F. Enzymic method for quantitative
determination of nanogram amounts of
total and oxidized glutathione: applications
to mammalian blood and other tissues.
Anal Biochem. 1969; 27: 502–22.
26. Awasthi S, Pandya U, Singhal SS, Lin JT,
Thiviyanathan V, Seifert WE Jr, Awasthi
YC, Ansari GA. Curcumin-glutathione
interactions and the role of human glu-
tathione S-transferase P1-1. Chem Biol
Interact. 2000; 128: 19–38.
27. Mathews S, Rao MNA. Interaction of cur-
cumin with glutathione. Int J
Pharmaceutics. 1991; 76: 257–9.
28. Oetari S, Sudibyo M, Commandeur JN,
Samhoedi R, Vermeulen NP. Effects of
curcumin on cytochrome P450 and glu-
tathione S-transferase activities in rat liver.
Biochem Pharmacol. 1996; 51: 39–45.
29. Sandur SK, Ichikawa H, Pandey MK,
Kunnumakkara AB, Sung B, Sethi G,
Aggarwal BB. Role of pro-oxidants and
antioxidants in the anti-inflammatory and
apoptotic effects of curcumin (diferuloyl-
methane). Free Radic Biol Med. 2007; 43:
568–80.
30. Syng-Ai C, Kumari AL, Khar A. Effect of
curcumin on normal and tumor cells: role
of glutathione and bcl-2. Mol Cancer Ther.
2004; 3: 1101–8.
31. Biswas SK, McClure D, Jimenez LA,
Megson IL, Rahman I. Curcumin
induces glutathione biosynthesis and
inhibits NF-kappaB activation and inter-
leukin-8 release in alveolar epithelial
cells: mechanism of free radical scav-
enging activity. Antioxid Redox Signal.
2005; 7: 32–41.
32. Hanselmann C, Mauch C, Werner S.
Haem oxygenase-1: a novel player in 
cutaneous wound repair and psoriasis?
Biochem J. 2001; 353: 459–66.
33. Wagener FA, van Beurden HE, von den
Hoff JW, Adema GJ, Figdor CG. The
heme-heme oxygenase system: a molecu-
lar switch in wound healing. Blood. 2003;
102: 521–8.
34. Willis D, Moore AR, Frederick R,
Willoughby DA. Heme oxygenase: a novel
target for the modulation of the inflammato-
ry response. Nat Med. 1996; 2: 87–90.
35. Andreadi CK, Howells LM, Atherfold PA,
Manson MM. Involvement of Nrf2, p38,
B-Raf, and nuclear factor-kappaB, but not
phosphatidylinositol 3-kinase, in induc-
tion of hemeoxygenase-1 by dietary
polyphenols. Mol Pharmacol. 2006; 69:
1033–40.
36. Borger DR, Essig DA. Induction of HSP 32
gene in hypoxic cardiomyocytes is attenu-
ated by treatment with N-acetyl-L-cysteine.
Am J Physiol. 1998; 274: 965–73.
37. Camhi SL, Alam J, Wiegand GW, Chin
BY, Choi AM. Transcriptional activation of
the HO-1 gene by lipopolysaccharide is
mediated by 5 distal enhancers: role of
reactive oxygen intermediates and AP-1.
Am J Respir Cell Mol Biol. 1998; 18:
226–34.
38. Rizzardini M, Carelli M, Cabello Porras
MR, Cantoni L. Mechanisms of endotoxin-
induced haem oxygenase mRNA accumu-
lation in mouse liver: synergism by glu-
tathione depletion and protection by N-
acetylcysteine. Biochem J. 1994; 304:
477–83.
39. Berberat PO, Katori M, Kaczmarek E,
Anselmo D, Lassman C, Ke B, Shen X,
Busuttil RW, Yamashita K, Csizmadia E,
Tyagi S, Otterbein LE, Brouard S,
Tobiasch E, Bach FH, Kupiec-Weglinski
JW, Soares MP. Heavy chain ferritin acts
as an antiapoptotic gene that protects liv-
ers from ischemia reperfusion injury.
FASEB J. 2003; 17: 1724–6.
40. Pham CG, Bubici C, Zazzeroni F, Papa S,
Jones J, Alvarez K, Jayawardena S, De
SE, Cong R, Beaumont C, Torti FM, Torti
SV, Franzoso G. Ferritin heavy chain
upregulation by NF-kappaB inhibits
TNFalpha-induced apoptosis by suppress-
ing reactive oxygen species. Cell. 2004;
119: 529–42.
41. Liu XM, Chapman GB, Peyton KJ, Schafer
AI, Durante W. Antiapoptotic action of car-
bon monoxide on cultured vascular
smooth muscle cells. Exp Biol Med. 2003;
228: 572–5.
J. Cell. Mol. Med. Vol 13, No 4, 2009
725© 2009 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
42. Brouard S, Otterbein LE, Anrather J,
Tobiasch E, Bach FH, Choi AM, Soares
MP. Carbon monoxide generated by heme
oxygenase 1 suppresses endothelial cell
apoptosis. J Exp Med. 2000; 192: 1015–26.
43. Brouard S, Berberat PO, Tobiasch E,
Seldon MP, Bach FH, Soares MP. Heme
oxygenase-1-derived carbon monoxide
requires the activation of transcription fac-
tor NF-kappa B to protect endothelial cells
from tumor necrosis factor-alpha-mediat-
ed apoptosis. J Biol Chem. 2002; 277:
17950–61.
44. Soares MP, Lin Y, Anrather J, Csizmadia
E, Takigami K, Sato K, Grey ST, Colvin
RB, Choi AM, Poss KD, Bach FH.
Expression of heme oxygenase-1 can
determine cardiac xenograft survival. Nat
Med. 1998; 4: 1073–7.
45. Petrache I, Otterbein LE, Alam J,
Wiegand GW, Choi AM. Heme oxyge-
nase-1 inhibits TNF-alpha-induced apop-
tosis in cultured fibroblasts. Am J Physiol
Lung Cell Mol Physiol. 2000; 278: 312–9.
